Optimistic about the company's development prospects, Yun Zhisheng (09678) received two executive directors to increase their shares by more than HK$5.1 million

Zhitong Finance App News, Yun Zhisheng (09678) announced that the board of directors was informed by Dr. Huang Wei, the controlling shareholder, executive director and CEO of the company, that it purchased a total of 56,000 H shares of the company with its own capital from July 6, 2026 to July 16, 2026, with an increase of about HK$3.9793 million.

The board of directors was also informed by Dr. Liu Shengping, the company's executive director, that it purchased a total of 15,140 H shares of the company with its own capital from July 7, 2026 to July 16, 2026, with an increase of approximately HK$1.125,900.

Dr. Wong Wai's increase in holdings and Dr. Liu Shengping's holdings are personal actions of Dr. Wong Wai and Dr. Liu Shengping, showing that they are confident in the company's overall development prospects and potential growth. Dr. Huang Wei also informed the company that it plans to continue to increase its H shares in the open market with its own capital in accordance with market conditions and applicable laws and regulations in the future. Dr. Wong Wai confirmed that the increase plan will be implemented in compliance with applicable laws, regulations and regulatory requirements (including the “Code for Corporate Acquisitions, Mergers and Share Repurchase”), and will ensure that the implementation and completion of the increase plan does not result in Dr. Wong Wai himself, or a concerted action group formed by Dr. Wong Wai, Dr. Leung Ka-yan, and Dr. Kang Hang in accordance with their agreed action arrangements, to submit a mandatory comprehensive offer in accordance with section 26 of the “Code of Corporate Acquisitions, Mergers and Share Buybacks”.